NewswireTODAY - /newswire/ - Delhi, India, 2009/03/03 - The present report analyzes Alzheimer’s disease treatment and diagnosis market and discusses major drugs being used for the treatment of AD in United States, Japan and China. It analyses major growth drivers and opportunities present in the market.

The Alzheimer’s disease (AD) diagnosis and therapy market is expanding with increasing number of cases worldwide. The current scenario shows bright outlook for diagnosis market. As early diagnosis of AD is not possible, there is a strong need of an early detection technique. United States, Europe and Japan are the three major markets for the treatment of AD. In China, the diagnosis and drug treatment of Alzheimer’s disease is extremely low, which represents a potential opportunity for market players.

The worldwide Alzheimer disease market is led by sales of Eisai/Pfizer and Aricept. Eisai/Pfizer’s Aricept (donepezil) and Forest pharmaceutical’s Namenda (memantine) are the market leaders in the United States. After cardiovascular diseases and cancer, AD is the third largest market in the world in terms of cost of treatment of the disease.

Aging population is a major cause of increasing number of Alzheimer patients and driving AD diagnosis and treatment market. Urbanization also contributes to the growing AD market. The unmet clinical needs are driving competitors to focus on R&D which ultimately leads to new product introduction and helps in market growth.

The report broadly includes the following:

1. Introduction

2. Alzheimer Drugs Market
2.1 Worldwide Market
Global Market Value
Growth Rate
Market Value by Drugs
Market Share

2.2 Alzheimer’s Market: United States
Market Value
Market Share

2.3 Chinese Alzheimer’s Market

3. Market Features

3.1 Key Trends
3.2 Market Opportunities
3.3 Significant Developments

4. Competitive Landscape

4.1 Drug Competition
4.2 Leading Players

5. Company Profiles

5.1 Forest Laboratories
5.2 Neuro-Hitech
5.3 Elan Corporation

6. Market Outlook

US Market
European Market

List of Tables
Global Alzheimer Market Value by Drugs (2007)
US Alzheimer Market by Drug Sales (2001-06)
US Alzheimer Market - Total Dispensed Scripts (2001-06)
Clinical Trials Phases of Alzheimer Drugs
US Alzheimer Treatment Market Forecast (2010-15E)
European Alzheimer Market Forecast (2011-15E)
Forest Laboratories- Sales by Business Segments (2006-08)
Forest Laboratories- Drug Sales (2006-08)
Elan Corp. - Revenue by Business Segments (2005-07)

List of Charts

Types of Prescription Medications
Global Alzheimer Market Value (2006-07)
Global Drugs Market Share (2007)
Drugs Market Value & Growth Rate (2006)
Global Alzheimer Drugs Market (2005)
Alzheimer’s Top Brands - Market Share (2001-06)
Medicine Market Share in China (2007)
Rate of Occurrence of Alzheimer in Western Countries (2007)
Alzheimer Drugs – Competitive Landscape
Alzheimer RX Trends
Neuro-Hitech - Revenue & Net Income (2005-07).

Agency / Source: Koncept Analytics

Availability: All Regions (Including Int'l)

Traffic Booster: [/] Quick NewswireToday Visibility Checker

Distribution / Indexing: [+]